BOT
Botanix Pharmaceuticals Ltd
Pharmaceuticals
·
Healthcare
11
comments
6
fund managers
past 90 days
About Botanix Pharmaceuticals Ltd
Botanix Pharmaceuticals Ltd. is a dermatology company specializing in the research and development of antimicrobial and dermatological products. Headquartered in West Perth, Australia, the firm operates across markets in Australia and the United States. Founded in 1984 by Matthew Callahan, Roger New, and Glen Travers, Botanix focuses on advancing medical treatments within the dermatology sector. The company provides investors with insights into its clinical pipeline and operational activities across its primary geographical segments.
Commentary Volume
11
Comments
6
Fund managers
0
Past 90 days
SOURCE
ACTION
COMMENT PREVIEW
FUND MANAGER
DATE
Loading...
.
​Loading...
Loading...
Loading...
Loading...
Source: Ipsum Capital Q4 Quarterly Letter · Published 14 March 2025
Report a problem
Loading...
.
Loading...
Loading...
Loading...
Loading...
§ Important Notice
The entries below are records originating from third-party statements. Thesis Tracker does not rank, recommend or endorse any fund manager, fund or security. Investment decisions should be made on the basis of the relevant Product Disclosure Statement and, where appropriate, advice from a licensed adviser.
Commentary
Sector
Healthcare
Market cap
$61M
Fund managers
6 managers
First covered
31 May 2024
Last updated
1 Oct 2025
Company Details
Related Themes
ic
Ipsum Capital
6 comments
ic
Amet Funds
4 comments
ic
Dolor
3 comments
Top Investors Covering MIN
§ Reminder
The entries above are records originating from third-party statements. Thesis Tracker does not rank, recommend or endorse any fund manager, fund or security. Investment decisions should be made on the basis of the relevant Product Disclosure Statement and, where appropriate, advice from a licensed adviser.
Frequently asked questions about Botanix Pharmaceuticals Ltd (ASX:BOT)
Frequently asked questions
Who is investing in Botanix Pharmaceuticals Ltd (ASX:BOT)?
Fund managers including Salter Brothers, Monash Investors, SG Hiscock & Company, Firetrail Investments, Antares Capital and Lennox Capital Partners have invested in Botanix Pharmaceuticals Ltd (ASX:BOT).
What is the short interest in Botanix Pharmaceuticals Ltd (ASX:BOT)?
The short interest in Botanix Pharmaceuticals Ltd (ASX:BOT) is 3.09% which makes it the 77th most shorted stock on the ASX. Of the 2.0B shares that Botanix Pharmaceuticals Ltd has on issue, 60.9M have been sold short.
What does Botanix Pharmaceuticals Ltd (ASX:BOT) do?
Botanix Pharmaceuticals Ltd. is a dermatology company specializing in the research and development of antimicrobial and dermatological products. Headquartered in West Perth, Australia, the firm operates across markets in Australia and the United States. Founded in 1984 by Matthew Callahan, Roger New, and Glen Travers, Botanix focuses on advancing medical treatments within the dermatology sector. The company provides investors with insights into its clinical pipeline and operational activities across its primary geographical segments.
Loading...